Sfoglia per AUTORE
RUBINI E
Collezione ASL Città di Torino
Items : 42
2023 ACR/EULAR classification criteria in existing research cohorts: an international study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 1;63(10):2770-2775. doi: 10.1093/rheumatology/keae058.
2024
ASL Città di Torino
Sciascia S; Roccatello D; Rossi D; Gimen Alonso C; Alba P; Rubini E; Barinotti A; Radin M; Cecchi I; Foddai SG;
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain. in Autoimmunity reviews / Autoimmun Rev. 2023 Nov;22(11):103454. doi: 10.1016/j.autrev.2023.103454. Epub 2023 Sep 22.
2023
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Elnaz R; Rubini E; Aluf O; Barinotti A; Cecchi I; Radin M; Manfredi M; Benucci M; Infantino M; Foddai S;
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach. in European journal of internal medicine / Eur J Intern Med. 2023 Jan;107:1-6. doi: 10.1016/j.ejim.2022.10.010. Epub 2022 Oct 20.
2023
ASL Città di Torino
Sciascia S; Roccatello D; Pengo V; Morotti A; Rubini E; Barinotti A; Arbrile M; Foddai SG; Radin M; Cecchi I;
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. in Journal of clinical pathology / J Clin Pathol. 2023 Dec;76(12):839-846. doi: 10.1136/jcp-2022-208199. Epub 2022 Sep 13.
2023
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Rubini E; Foddai SG; Cecchi I; Barinotti A; Radin M;
Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.
2023
ASL Città di Torino
Sciascia S; Cozzi M; Del Vecchio G; De Simone E; Rossi D; Rubini E; Cecchi I; Naretto C; Roccatello D; Fenoglio R; Kamgaing J; Caniggia I;
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain in Autoimmunity Reviews
2023
ASL Città di Torino
Infantino M; Foddai S; Manfredi M; Benucci M; Radin M; Cecchi I; Barinotti A; Aluf O; Rubini E; Elnaz R; Menegatti E; Roccatello D; Sciascia S;
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. in International journal of cardiology / Int J Cardiol. 2022 Sep 15;363:185-189. doi: 10.1016/j.ijcard.2022.06.040. Epub 2022 Jun 14.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Rubini E; Arbrile M; Foddai SG; Cecchi I; Radin M; Barinotti A;
Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.
2022
ASL Città di Torino
Truglia S; Urban ML; Sebastiani GD; Ramoni VL; Rubini E; Raffeiner B; Pazzola G; Radin M; Nalli C; Lazzaroni MG; Hoxha A; Larosa M; Gerosa M; Franceschini F; Fischetti F; Fioravanti A; Emmi G; Conti F; Chighizola CB; Cecchi I; Carubbi F; Canti V; Calligaro A; Barinotti A; Andreoli L; Alunno A; Alessandri C; Foddai SG; Sciascia S; et alii...
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):1612-1620. doi: 10.1055/a-1798-2400. Epub 2022 Mar 15.
2022
ASL Città di Torino
Tincani A; Roccatello D; Urban ML; Sebastiani GD; Truglia S; Rubini E; Raffeiner B; Radin M; Ramoni VL; Nalli C; Pazzola G; Lazzaroni MG; Larosa M; Gerosa M; Hoxha A; Franceschini F; Fischetti F; Emmi G; Fioravanti A; Chighizola CB; Conti F; Cecchi I; Canti V; Carubbi F; Calligaro A; Andreoli L; Barinotti A; Alessandri C; Alunno A; et alii...
Serum Biomarkers of Renal Fibrosis: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 16;23(22):14139. doi: 10.3390/ijms232214139.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N
2021
ASL Città di Torino
Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Rubini E; Cecchi I; Radin M; Schreiber K;
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.
2021
ASL Città di Torino
Roccatello D; Barinotti A; Foddai SG; Rubini E; Radin M; Cecchi I; Sciascia S;
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
AOU Città della Salute di Torino
ASL Città di Torino
AO Ordine Mauriziano
Mengozzi G; Roccatello D; Rossi D; Giachino O; Baldovino S; Vaccarino A; Bazzan M; Rubini E; Bertero MT; Bertolaccini ML; Cecchi I; Sciascia S; Radin M;
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.
2021
ASL Città di Torino
Roccatello D; Sciascia S; Rubini E; Barinotti A; Cecchi I; Foddai SG; Radin M;
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. in Thrombosis research / Thromb Res. 2021 Jun;202:100-103. doi: 10.1016/j.thromres.2021.03.019. Epub 2021 Mar 22.
2021
ASL Città di Torino
Sciascia S; Casas S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Cecchi I; Radin M; Foddai S;
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease. in Arthritis care & research / Arthritis Care Res (Hoboken). 2021 Dec;73(12):1804-1808. doi: 10.1002/acr.24391. Epub 2021 Oct 4.
2021
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano
Bertero T; Govoni M; Benedetto C; Andrade D; Franceschini F; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Cecchi I; Radin M; Schreiber K; Marozio L; Roccatello D; Andreoli L; Sciascia S;
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Rubini E; Cecchi I; Barinotti A; Foddai SG; Radin M;
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy. in Kidney international reports / Kidney Int Rep. 2021 Feb 3;6(4):1081-1087. doi: 10.1016/j.ekir.2021.01.027. eCollection 2021 Apr.
2021
ASL Città di Torino
Rossi D; Rahbani E; Rubini E; Quattrocchio G; Ferro M; Fenoglio R; Alpa M; Naretto C; Sciascia S; Roccatello D;
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino
Roccatello D; Vaccarino A; Rossi D; Barinotti A; Foddai SG; Rubini E; Cecchi I; Radin M; Sciascia S;
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes in Clinical and Experimental Rheumatology
2021
ASL Città di Torino
Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Cecchi I; Rubini E; Schreiber K; Radin M;
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2020 Sep 1;59(9):2412-2418. doi: 10.1093/rheumatology/kez620.
2020
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano
Roccatello D; Marozio L; Bertero T; Govoni M; Benedetto C; Franceschini F; Andrade D; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Schreiber K; Cecchi I; Radin M; Andreoli L; Sciascia S;
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. in Autoimmunity reviews / Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.
2020
ASL Città di Torino
Mahler M; Roccatello D; Menegatti E; Fenoglio R; Baldovino S; Foddai SG; Rubini E; Cecchi I; Casas S; Bentow C; Seaman A; Ramirez C; Radin M; Sciascia S;
Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2020 Oct;72(10):1774-1776. doi: 10.1002/art.41401. Epub 2020 Sep 6.
2020
ASL Città di Torino
Roccatello D; Rubini E; Cecchi I; Vaccarino A; Montaruli B; Montabone E; Carignola R; Bertero T; Bazzan M; Sciascia S; Radin M; Baldovino S;
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities. in Journal of thrombosis and haemostasis : JTH / J Thromb Haemost. 2020 Nov;18(11):2921-2928. doi: 10.1111/jth.15053. Epub 2020 Sep 21.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Marozio L; Benedetto C; Donati Marello B; Roccatello D; Manetta T; Mengozzi G; Menegatti E; Barinotti A; Orpheu G; Rubini E; Gaito S; Cecchi I; Radin M; Foddai SG; Sciascia S;
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469.
2020
ASL Città di Torino
Rossi D; Roccatello D; Baldovino S; Foddai SG; Rubini E; Crosasso P; Favuzzi MD; Osella S; Valeria M; Di Gregorio F; Buccarano N; Di Nunzio P; Cecchi I; Radin M; Sciascia S;
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2020 Jun;50(3):553-556. doi: 10.1016/j.semarthrit.2020.01.007. Epub 2020 Jan
2020
ASL Città di Torino
Cuadrado MJ; Sciascia S; Roccatello D; Rubini E; Schreiber K; Cecchi I; Radin M;
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12.
2020
ASL Città di Torino
Roccatello D; Menegatti E; Alba P; Escudero A; Foddai SG; Rubini E; Guiñazu F; Ladehesa PL; Radin M; Rossi D; Massara C; Cecchi I; Sciascia S;
Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies. in Biomedicines / Biomedicines. 2020 Dec 17;8(12):622. doi: 10.3390/biomedicines8120622.
2020
ASL Città di Torino
Sciascia S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Foddai SG; Cecchi I; Radin M;
Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing. in International journal of molecular sciences / Int J Mol Sci. 2020 Dec 15;21(24):9551. doi: 10.3390/ijms21249551.
2020
ASL Città di Torino
Menegatti E; Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;
Treatment of antiphospholipid syndrome. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2020 Dec;221:108597. doi: 10.1016/j.clim.2020.108597. Epub 2020 Sep 19.
2020
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Barinotti A; Rubini E; Foddai SG; Radin M; Cecchi I;
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. in Journal of nephrology / J Nephrol. 2020 Aug;33(4):757-762. doi: 10.1007/s40620-019-00698-9. Epub 2020 Jan 23.
2020
ASL Città di Torino
ASL Torino 5
Roccatello D; Rubini E; Miraglia P; Besso L; Baldovino S; Rossi D; De Marchi A; Fenoglio R; Cecchi I; Sciascia S; Radin M;
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome. in Thrombosis and haemostasis / Thromb Haemost. 2020 Apr;120(4):592-598. doi: 10.1055/s-0040-1705115. Epub 2020 Mar 17.
2020
ASL Città di Torino
Sciascia S; Bertolaccini ML; Roccatello D; Schreiber K; Rubini E; Cecchi I; Foddai SG; Radin M;
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166.
2019
ASL Città di Torino
López Pedrera C; Roccatello D; Collantes E; Sciascia S; Menegatti E; Barbarroja N; Pérez-Sánchez C; Aguirre MÁ; Rubini E; Cecchi I; Radin M; Arias de la Rosa I;
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2019 Feb;48(4):741-744. doi: 10.1016/j.semarthrit.2018.04.001. Epub 2018 Apr
2019
ASL Città di Torino
Roccatello D; Bazzan M; Rubini E; Cecchi I; Radin M; Sciascia S;
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. in Frontiers in immunology / Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.
2019
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara
Mahler M; Vaccarino A; Ferro M; Baldovino S; Muccini E; Pergolini P; Mengozzi G; Montaruli B; Rolla R; Scotta A; Rubini E; Radin M; Cecchi I; Sciascia S; Menegatti E; Roccatello D;
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients. in Frontiers in medicine / Front Med (Lausanne). 2019 Sep 26;6:211. doi: 10.3389/fmed.2019.00211. eCollection 2019.
2019
ASL Città di Torino
Roccatello D; Rodríguez-Carrio J; Suárez A; Rubini E; Radin M; Cecchi I; Sciascia S;
Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients. in Thrombosis research / Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2.
2018
ASL Città di Torino
Mahler M; Sciascia S; Roccatello D; Schreiber K; Rubini E; Cecchi I; Radin M;
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. in Annals of the rheumatic diseases / Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18.
2018
ASL Città di Torino
Roccatello D; Rossi D; Cecchi I; Radin M; Rubini E; Sciascia S;
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphosphospholipid syndrome: A multicenter study in Arthritis and Rheumatology
2018
ASL Città di Torino
AOU Città della Salute di Torino
Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Vaccarino A; Roccatello D; Sciascia S; Batticciotto A; Prato G; Antivalle M; Ditto MC; Agosti M; Cumbo E; Talotta R; Atzeni F; Sarzi-Puttini P;